Tradestie Institutional Equity Comparison Engine

DXCM vs VRTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DXCM Overall Edge

DXCM Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Valuation, Momentum & Technical, Options & Structure while VRTX counters with relative strength in Growth & Margin. Fundamentally, DXCM trades at 25.3x Forward P/E with 24.0% operating margin (+11.2% YoY revenue) versus VRTX at 25.9x Forward P/E and 37.8% operating margin (+11.8% YoY). In options structure, DXCM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against VRTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DXCM
DXCM 25.3x vs VRTX 25.9x Fwd P/E
Growth & Margin Winner VRTX
Op Margin 24.0% vs 37.8% ยท YoY +11.2% vs +11.8%
Momentum & Technical Winner DXCM
1Y +32.8% vs +22.3% ยท 52W Pos 63% vs 66%
Options & Structure Winner DXCM
CONSOLIDATION (15th %ile IV) vs CONSOLIDATION (33rd %ile IV)
DXCM NASDAQ
DexCom, Inc.
Surgical & Medical Instruments & Apparatus
$79.32
-1.08% 1D
Market Cap $29.9B
1M Return +1.28%
1Y Return +32.8%
Forward P/E 25.3x
Unified AI Score
50.8 / 100 HOLD
Tech 49.0 Fund 56.0 Flow 68.0 Mom 54.0
VRTX NASDAQ
Vertex Pharmaceuticals Inc
Pharmaceutical Preparations
$515.02
-1.08% 1D
Market Cap $132.0B
1M Return -3.77%
1Y Return +22.32%
Forward P/E 25.9x
Unified AI Score
40.9 / 100 SELL
Tech 25.0 Fund 47.0 Flow 69.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DXCM +32.8% VRTX +22.32% Spread: +10.48 pp (DXCM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DXCM Revenue VRTX Revenue DXCM Op. Margin VRTX Op. Margin Margin Edge
FY2018 $1.03B $3.05B -18.1% 20.8% VRTX
FY2019 $1.48B $4.16B 9.6% 28.8% VRTX
FY2020 $1.93B $6.21B 15.5% 46.0% VRTX
FY2021 $2.45B $7.57B 10.9% 36.7% VRTX
FY2022 $2.91B $8.93B 13.4% 48.2% VRTX
FY2023 $3.62B $9.87B 16.5% 38.8% VRTX
FY2024 $4.03B $11.0B 14.9% -2.1% DXCM
FY2025 $4.66B $12.0B 19.6% 34.8% VRTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DXCM (4) vs VRTX (6)
Institutional Metric DXCM VRTX Criterion Row Winner
Market Capitalization Scale $29.9B $132.0B Larger Scale VRTX
Trailing P/E Ratio Valuation 31.6x 33.5x Lower Multiple DXCM
Forward P/E Ratio Valuation 25.3x 25.9x Lower Multiple DXCM
Revenue Growth (YoY) Growth +11.2% +11.8% Higher Growth VRTX
Operating Margin (TTM) Profitability 24.0% 37.8% Higher Margin VRTX
Net Profit Margin Profitability 19.4% 30.7% Higher Margin VRTX
Return on Equity (ROE) Capital Efficiency 37.7% 20.8% Higher ROE DXCM
52-Week Range Position Momentum 63% ($57โ€“$93) 66% ($412โ€“$569) Stronger Trend VRTX
Beta / 30D Volatility Risk Regime 0.59ฮฒ ยท 43% Vol 0.35ฮฒ ยท 28% Vol Lower Realized Risk VRTX
Unified Institutional Score Composite Signal 50.8 / 100 (HOLD) 40.9 / 100 (SELL) Higher Composite DXCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DXCM vs VRTX Buy Guide
DXCM CONSOLIDATION
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live DXCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VRTX CONSOLIDATION
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VRTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DXCM nor VRTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.